期刊文献+

衡阳市非酒精性脂肪肝患病率及危险因素分析 被引量:4

Analysis of the Prevalence Rate of Nonalcoholic Fatty Liver Disease and its Risk Factors in Hengyang City
下载PDF
导出
摘要 目的了解健康人群中非酒精性脂肪肝病(NAFLD)患病率及其相关危险因素,为防治NAFLD提供依据。方法以衡阳市南华大学第二附属医院健康体检的3261例人群为研究对象,以是否患NAFLD将研究对象分为NAFLD组和对照组。收集相关体检资料进行显著性分析。结果NAFLD总检出率为16.6%,有明显的性别、年龄差异;不同职业人群NAFLD患病率有所不同;NAFLD组各危险因素检出率均高于对照组;除高密度脂蛋白外,NAFLD组各临床指标均值均高于对照组;Logistic回归分析结果显示年龄、体重指数、甘油三酯、尿酸、丙氨酸氨基转移酶、高密度脂蛋白与NAFLD的发生密切相关。结论肥胖、年龄、甘油三酯、尿酸和丙氨酸氨基转移酶活性升高是NAFLD的危险因素,高密度脂蛋白是其保护因素,应注意NAFLD的防治。 Objective To investigate the prevalence rate of nonalcoholic fatty liver disease and its risk factors among the people taken health examination and provide scientific basis for prevention and treatment. Methods The medical examination results of 3 261 cases were collected for statistical analysis from the Second Affiliated Hospital of University of South China. Results The total incidence of nonalcoholic fatty liver disease in our study was 16.6%. There ate significant differences between gender groups and among age groups. The incidence rate of NAFLD is varied form different occupations and the risk factors for NAFLD group had higher detection rate. In addition to high - density lipoprotein, all clinical indicators of NAFLD group are higher than that of control. Multiple logistic regression analysis revealed that the risk factors of NAFLD including AGE, BMI, TG, UA, ALT, HDL- C and hypertension were highly relative to NALFD. Conclusion The risk factors for NAFLD are obesity, age ,triglycerides, uric acid and alanine amino - transferase activity increased. HDL- C is the protective factor for NALFD which should be paid attention to for NAFLD prevention and treatment.
出处 《南华大学学报(医学版)》 2010年第2期190-193,共4页 Journal of Nanhua University(Medical Edition)
关键词 非酒精性脂肪性肝病 患病率 危险因素 LOGISTIC回归分析 nonalcoholic fatty liver disease prevalence rate risk factors logistic regression analysis
  • 相关文献

参考文献5

二级参考文献54

  • 1张桂欣,张秀巧,周秀荣,石文彬,刘淑清,赵瑞光,谢素华.95例肥胖儿童血脂和免疫球蛋白调查分析[J].临床儿科杂志,1994,12(5):292-293. 被引量:2
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3吴光驰,郭素怡,王乃坤,朱宇平.北京地区468名少儿肥胖及血压改变的八年随访观察[J].中华医学杂志,1997,77(1):18-21. 被引量:54
  • 4SZETOCC,LAI KB,CHOW KM,et al.Differential effects of transforming growth factor-beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell[J].Nephron Exp Nephrol,2005,99 (4):e95-e104.
  • 5KIVIR1KKO KL,LAITINEN O,PROCKOP DJ.Modifications of a specific assay for hydroxyproline in urine[J].Anal Biochem,1967,19:249-255.
  • 6CHEVALLIER M,GUERRET S,CHOSSEGROS P et al.A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens:comparison with morphometric studies[J].Hepatology,1994,20(2):349-55.
  • 7OKAZAKI I,WATAABE T,HOZAWA S,et al.Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery[J].Keio Med,2001,50(2):58-65.
  • 8WU J,NORTON PA.Animal models of liver fibrosis[J].J Gastroenterol,1996,31(12):1137-1143.
  • 9PINZANI M,ROMBOUS K,COLAGRANDE S.Fibrosis in chronic liver diseases:diagnosis and management[J].Hepatology,2005,42 Suppl(1):S22-36.
  • 10GABRIELA GR,MARIA CG.Liver fibrosis and chronic viral hepatitis[J].Arch Med Res,2007,38:644-651.

共引文献1891

同被引文献37

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部